Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1974 2
1978 1
1980 1
1981 2
1984 2
1985 1
1988 1
1992 1
1994 2
1995 1
1997 1
1999 1
2000 2
2001 3
2002 3
2003 2
2004 3
2005 1
2006 6
2007 4
2008 8
2009 10
2010 6
2011 12
2012 16
2013 8
2014 11
2015 11
2016 11
2017 12
2018 6
2019 8
2020 15
2021 24
2022 15
2023 14
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

206 results

Results by year

Filters applied: . Clear all
Page 1
Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial.
Bardia A, Messersmith WA, Kio EA, Berlin JD, Vahdat L, Masters GA, Moroose R, Santin AD, Kalinsky K, Picozzi V, O'Shaughnessy J, Gray JE, Komiya T, Lang JM, Chang JC, Starodub A, Goldenberg DM, Sharkey RM, Maliakal P, Hong Q, Wegener WA, Goswami T, Ocean AJ. Bardia A, et al. Among authors: goswami t. Ann Oncol. 2021 Jun;32(6):746-756. doi: 10.1016/j.annonc.2021.03.005. Epub 2021 Mar 16. Ann Oncol. 2021. PMID: 33741442 Free article. Clinical Trial.
TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors.
Tagawa ST, Balar AV, Petrylak DP, Kalebasty AR, Loriot Y, Fléchon A, Jain RK, Agarwal N, Bupathi M, Barthelemy P, Beuzeboc P, Palmbos P, Kyriakopoulos CE, Pouessel D, Sternberg CN, Hong Q, Goswami T, Itri LM, Grivas P. Tagawa ST, et al. Among authors: goswami t. J Clin Oncol. 2021 Aug 1;39(22):2474-2485. doi: 10.1200/JCO.20.03489. Epub 2021 Apr 30. J Clin Oncol. 2021. PMID: 33929895 Free PMC article. Clinical Trial.
A tissue-specific atlas of mouse protein phosphorylation and expression.
Huttlin EL, Jedrychowski MP, Elias JE, Goswami T, Rad R, Beausoleil SA, Villén J, Haas W, Sowa ME, Gygi SP. Huttlin EL, et al. Among authors: goswami t. Cell. 2010 Dec 23;143(7):1174-89. doi: 10.1016/j.cell.2010.12.001. Cell. 2010. PMID: 21183079 Free PMC article.
Sacituzumab govitecan in previously treated hormone receptor-positive/HER2-negative metastatic breast cancer: final results from a phase I/II, single-arm, basket trial.
Kalinsky K, Diamond JR, Vahdat LT, Tolaney SM, Juric D, O'Shaughnessy J, Moroose RL, Mayer IA, Abramson VG, Goldenberg DM, Sharkey RM, Maliakal P, Hong Q, Goswami T, Wegener WA, Bardia A. Kalinsky K, et al. Among authors: goswami t. Ann Oncol. 2020 Dec;31(12):1709-1718. doi: 10.1016/j.annonc.2020.09.004. Epub 2020 Sep 15. Ann Oncol. 2020. PMID: 32946924 Free article. Clinical Trial.
Cell-Penetrating Protein/Corrole Nanoparticles.
Soll M, Goswami TK, Chen QC, Saltsman I, Teo RD, Shahgholi M, Lim P, Di Bilio AJ, Cohen S, Termini J, Gray HB, Gross Z. Soll M, et al. Among authors: goswami tk. Sci Rep. 2019 Feb 19;9(1):2294. doi: 10.1038/s41598-019-38592-w. Sci Rep. 2019. PMID: 30783138 Free PMC article.
Sublingual drug delivery.
Goswami T, Jasti B, Li X. Goswami T, et al. Crit Rev Ther Drug Carrier Syst. 2008;25(5):449-84. doi: 10.1615/critrevtherdrugcarriersyst.v25.i5.20. Crit Rev Ther Drug Carrier Syst. 2008. PMID: 19062634 Review.
The sarcoid-lymphoma syndrome.
Goswami T, Siddique S, Cohen P, Cheson BD. Goswami T, et al. Clin Lymphoma Myeloma Leuk. 2010 Aug;10(4):241-7. doi: 10.3816/CLML.2010.n.052. Clin Lymphoma Myeloma Leuk. 2010. PMID: 20709659 Review.
Anthropomorphic Characterization of Ankle Joint.
Gundapaneni D, Tsatalis JT, Laughlin RT, Goswami T. Gundapaneni D, et al. Among authors: goswami t. Bioengineering (Basel). 2023 Oct 17;10(10):1212. doi: 10.3390/bioengineering10101212. Bioengineering (Basel). 2023. PMID: 37892942 Free PMC article.
206 results